Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation

Acta Psychiatr Belg. 1976 Jan-Feb;76(1):157-66.

Abstract

Pipamperone solution or tablets were prescribed for four weeks to 188 patients (3-100 years) with behavior disorders. Fifty of these (group A) were mental retardates, the remaining 138 (group B) had a normal I.Q. Their doses were gradually increased until optimal effect was reached. Nearly all 17 items of a behaviour rating scale had improved very significantly by the end of the fourth week, while in 82% of the patients of group A and 76% of group B results were rated good to very good. Also, pipamperone proved to be far superior to previous psychotropic drugs in patients who had been treated before.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alcoholism / complications
  • Butyrophenones / therapeutic use*
  • Chemical Phenomena
  • Chemistry
  • Child
  • Child Behavior Disorders / drug therapy*
  • Child, Preschool
  • Drug Evaluation
  • Epilepsy / complications
  • Female
  • Humans
  • Intellectual Disability / complications
  • Isonipecotic Acids / therapeutic use
  • Male
  • Middle Aged
  • Psychotic Disorders / complications
  • Social Behavior Disorders / drug therapy*
  • Tranquilizing Agents / therapeutic use*

Substances

  • Butyrophenones
  • Isonipecotic Acids
  • Tranquilizing Agents
  • pipamperone